Dr. Isaac Klein is a Medical Oncology Fellow and Postdoctoral Fellow at the Dana-Farber Cancer Institute of Harvard University and the Whitehead Institute of the Massachusetts Institute of Technology, in the laboratory of Dr. Richard Young. His research focuses on understanding the role of transcriptional dysregulation in malignancy, and how this might reveal opportunities for novel therapies.
Dr. Klein was an undergraduate at Cornell University in the Department of Biological and Agricultural Engineering. He completed a PhD in Biology at The Rockefeller University and an MD at the Weill Cornell Medical College. He completed Internal Medicine residency training at the Brigham and Women’s Hospital of Harvard University, serving as Chief Medical Resident at the West Roxbury Veteran’s Affairs Hospital. He is a recipient of a Rockefeller Hearst Fellowship, a Cancer Research Institute Fellowship, The Franklyn Ellenbogen Prize in Hematology and Oncology, and a Keystone Scholarship.